
GC62875
BRD3731
Also known as (4S)-3-(2,2-dimethylpropyl)-4,7,7-trimethyl-4-phenyl-2,6,8,9-tetrahydropyrazolo[3,4-b]quinolin-5-one
BRD3731 is a selective GSK3β inhibitor, with IC50s of 15 nM and 215 nM for GSK3β and GSK3α, respectively
ChemicalCAS2056262-07-6MW377.52FormulaC24H31N3O
- CAS number
- 2056262-07-6
- Molecular weight
- 377.52
- Formula
- C24H31N3O
- Solubility
- DMSO : 50 mg/mL (132·44 mM; Need ultrasonic)
- InChIKey
- YZRXTIGAQRIAEX-XMMPIXPASA-N
- Catalogue number
- GC62875
- Brand
- GLPBIO
Computed properties PubChem CID 135567205 · XLogP 5.6 · TPSA 57.8 Ų · H-bond donors 2
- XLogP
- 5.6
- TPSA
- 57.8 Ų
- H-bond donors
- 2
- H-bond acceptors
- 3
- Rotatable bonds
- 3
- Heavy atoms
- 28
SMILES C[C@]1(C2=C(CC(CC2=O)(C)C)NC3=NNC(=C31)CC(C)(C)C)C4=CC=CC=C4
Computed descriptors from PubChem (CID 135567205), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il